[Reappraisal role of locoregional radiation therapy in metastatic cancers]

Bull Cancer. 2017 Jan;104(1):86-91. doi: 10.1016/j.bulcan.2016.11.008. Epub 2016 Dec 9.
[Article in French]

Abstract

Recent innovations in oncology area helped to improve the prognosis of certain cancers including metastatic ones with a decrease in mortality. Recommendations describe the treatment of metastatic cancer as systemic therapy or complementary care and the role of locoregional treatment in the treatment plan only occurs in a palliative context. Currently, in the clinical practice, out of "the evidence based medicine", an early locoregional therapy (surgery or radiation therapy) can be proposed in several cases of metastatic cancers. The aim of the present review is to describe the role of the primary tumor radiation therapy in metastatic disease. In metastatic breast, prostate, cervix, rectal or nasopharyngeal cancers, locoregional treatment including radiation therapy can, in some cases, be discussed and decided in MDT. Ongoing clinical trials in these locations should soon precise the benefit of this locoregional treatment. It will also be important to define the specific criteria in order to select patients who could benefit from this treatment.

Keywords: Breast; Cavum; Locoregional; Locorégional; Metastatic; Métastatique; Prostate; Radiation therapy; Radiothérapie; Sein.

Publication types

  • Review

MeSH terms

  • Breast Neoplasms / mortality
  • Breast Neoplasms / radiotherapy*
  • Breast Neoplasms / secondary
  • Breast Neoplasms / surgery
  • Female
  • Humans
  • Male
  • Nasopharyngeal Neoplasms / mortality
  • Nasopharyngeal Neoplasms / radiotherapy*
  • Nasopharyngeal Neoplasms / secondary
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / radiotherapy*
  • Prostatic Neoplasms / secondary
  • Rectal Neoplasms / mortality
  • Rectal Neoplasms / radiotherapy*
  • Rectal Neoplasms / secondary
  • Uterine Neoplasms / mortality
  • Uterine Neoplasms / radiotherapy*
  • Uterine Neoplasms / secondary